PharmaBoardroom

De-risking Drug Discovery with AI

On the supply side, AI appears to herald the prospect of de-risking the drug discovery process and doing away with many of the traditional…

Demystifying AI

The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to expand at an impressive 20 percent…

Most Looked at Countries in 2019

PharmaBoardroom had the opportunity to sit down with over six hundred key stakeholders in the life sciences industry across fifteen different…

Countering Hospital-Acquired Infections with a Culture of Safety

Becton Dickinson's Fiona Garín looks at the rise of Healthcare-Acquired Infections (HAIs) in Europe and how an industry-wide culture of safety needs…

Péter Holchacker – Director, AIPM, Hungary

Dr Péter Holchacker, director of the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM), shares his insights on the key…

Jakub Dvořáček – CEO, AIFP, Czech Republic

Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement…

New Taiwan Pharma Report November 2019 Out Now

Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of…

New Thailand Pharma Report November 2019 Out Now

PharmaBoardroom's latest report: Healthcare & Life Sciences Review: Thailand is available for download now. Thailand is in the…

Collaboration: The IFPMA’s Route to Reaching the…

With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters…

Dubai Aims to Go Paperless by 2021

Dubai's government has announced its ambition to go completely paper-free by the end of the year 2021. Its health authority has recently upgraded to a…

Biosimilars and Biologics: Thailand

Biosimilars and biologics in Thailand - a legal guide. Prepared in association with Tilleke & Gibbins, a leading law firm in Thailand, this is an…

Orphan Drugs and Rare Diseases: Thailand

An intro to the legal situation for orphan drugs and rare diseases in Thailand. Prepared in association with Tilleke & Gibbins, a leading law…

Tagged with AI